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CHAPTER I 
 
INTRODUCTION 
 
Gastric Cancer 
Although gastric cancer is the second leading cause of cancer-death world-wide
1
, 
incidence rates vary widely between geographic regions. The highest incidence rates are seen in 
Eastern Asia, Eastern Europe, and Central and South America
2
.  Most often, incidence rates of 
gastric cancer are higher in developing countries
2
 with the exception of Japan having the highest 
incidence rate in the world
3
. Approximately 10% of gastric cancers are non-Hodgkin’s 
lymphomas and leimyosarcomas while 90% are adenocarcinomas
4
. 
There are two types of gastric adenocarcinoma that differ in their epidemiological and 
histopathological characteristics
4,5
. Diffuse-type gastric adenocarcinomas are typically 
experienced by younger individuals and affect men and women with equal incidence.       
Diffuse-type gastric adenocarcinomas are characterized by neoplastic cells infiltrating the 
stomach and a general thickening of the stomach wall without a discrete tumor mass. In contrast, 
intestinal-type gastric adenocarcinoma is more commonly seen in older individuals and presents 
more often in men than in women. Moreover, intestinal-type gastric adenocarcinomas develop 
following a well-defined series of histological steps, where gland-like structures ulcerate and 
form tumors. In the series of histological steps, normal tissue is initiated (most often by 
superficial gastritis) and progresses through stages of atrophic gastritis, metaplasia, dysplasia and 
finally adenocarcinoma. 
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In contrast to colon adenocarcinoma, which also proceeds through a series of discrete 
histological steps
6
, there are no mutational events consistently associated with the initiation of 
gastric adenocarcinoma
5
. Rather, a bacterial pathogen, Helicobacter pylori (H. pylori), is widely 
considered to be the initiating agent for a significant percentage of gastric cancers
5
. However, the 
mechanisms by which H. pylori contributes to gastric carcinogenesis are not completely 
understood.  
 
Helicobacter pylori 
H. pylori is a Gram-negative curved-bacillus that selectively colonizes the stomach.       
H. pylori is able to survive the harsh acidic gastric environment by metabolizing urea to 
ammonia which creates a higher pH microenvironment immediately surrounding the bacterium
7
. 
Though the presence of H. pylori had been noted in pathological specimens as early as the 19
th
 
century, it was not classified until 1984 when Robin Warren and Barry Marshall successfully 
cultured the organism from gastric biopsies
8
.  The World Health Organization (WHO) classified 
H. pylori as a class I carcinogen in 1994
5
. Subsequent studies have continued to demonstrate that 
H. pylori infection significantly augments gastric cancer risk
7
, and H. pylori-induced gastritis is 
currently considered to be the highest risk factor for gastric cancer
5
. Although H. pylori 
colonizes 50% of the world’s population, and most infected individuals develop chronic gastritis, 
only 1% of infected individuals develop gastric cancer
5.  It is widely believed that a patient’s 
disease outcome is ultimately the result of interplay between environmental factors, bacterial 
virulence factors, and host factors. 
One environmental factor that alters risk for H. pylori-induced gastric cancer is             
co-infection with other pathogens. For example, co-infection with helminth parasites can lower 
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risk for gastric cancer
7
. A potential explanation for this phenomenon is that co-infection with a 
helminth parasite could skew the immune response to a Th2 response rather than a                  
pro-inflammatory Th1 response
9,10
. In contrast, co-infection with Epstein Barr Virus (EBV) can 
raise the risk for gastric cancer
4,11
. The mechanisms by which EBV contributes to gastric 
carcinogenesis are not completely understood, though one study has demonstrated that EBV can 
induce promoter methylation of a tumor suppressor gene, Pten
12
. This would be especially 
disadvantageous to the host during co-infection with H. pylori which can activate Akt
13
. 
Diet is another environmental factor that can affect the risk for gastric cancer, and one 
strong dietary risk factor is salt
7
. Epidemiological studies
14–16
 as well as in vivo studies in 
gerbils
17–20
 and mice
21
 have demonstrated that diets high in salt increase the risk of gastric cancer 
in the context of H. pylori infection. Possible explanations for the increased risk of gastric cancer 
include damaging the mucosa directly to allow carcinogens into the tissue
7
, upregulation of 
inflammatory cytokines
7
 and increasing expression of H. pylori virulence factors
22,23
.  
There are several virulence factors, including those encoded by the cytotoxin-associated 
gene pathogenicity island (cag-PAI) which have been extensively shown to affect H. pylori-
induced gastric cancer risk. The cag-PAI is a 27 gene locus, and persons infected with a cag-PAI 
positive strain are at higher risk for peptic ulcer disease, atrophic gastritis and distal gastric 
adenocarcinoma compared to persons colonized with cag-PAI negative strains
24–31
. The cag-PAI 
encodes genes whose products make a type IV secretion system which translocates the gene 
product of CagA as well as peptidoglycan into host cells
5
. Upon entering host cells, CagA can be 
phosphorylated on EPIYA motifs in its carboxyl terminus by Src and Abl kinases
5
. However, 
CagA can affect host cells in both phosphorylation-dependent and phosphorylation-independent 
manners. Phosphorylated CagA alters cell signaling by activating extracellular regulated kinases 
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1 and 2 (ERK1/2)
32
 and by deactivating focal adhesion kinase (FAK) and Src
33,34
.                  
Non-phosphorylated CagA induces -catenin translocation into the nucleus35 and has also been 
shown to induce a loss of cell polarity
36–39
. 
 Another important H. pylori virulence factor is VacA
7
. Cellular consequences of binding 
VacA include disruption of epithelial cell barriers, changes in inflammatory response, disruption 
of late endosomes resulting in vacuoles, and release of Cytochrome c to induce apoptosis
40–46
. 
The gene locus for VacA is divided into four regions, the signal (s) region, the intermediate (i) 
region, the d region, and the middle (m) region
47,48
. There is diversity seen within the sequences 
of these regions, and varying degrees of activity of VacA are observed between strains. For 
example, s1m1 strains induce more vacuolation than s1m2 strains
49
, and s1m1, i1 and d1 strains 
are associated with gastric ulcer disease and gastric cancer
48,50–54
.  
Finally, in addition to environmental factors and bacterial virulence factors, there are also 
host factors that alter risk for gastric cancer
7
. Arguably the most critical host factors that augment 
the risk for gastric cancer are involved in the host inflammatory response. In addition to 
promoting inflammation by activating cyclooxygenase enzymes to synthesize PGE2
7
, a potent 
stimulator of inflammation in the gastrointestinal system, H. pylori also induces a strong and 
persistent inflammatory immune response largely mediated by Th1 cells
55
.  Macrophages are 
recruited to the stomach early during infection
56,57
 and are critical for initiating the inflammatory 
response to H. pylori
58
. Macrophages contribute to gastric carcinogenesis risk in at least two 
ways. First, they are required to establish the inflammatory response that acts as an initiating 
event
58
. Second, macrophages produce reactive oxygen and nitrogen species, which can induce 
DNA damage
59
.   
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Matrix Metalloproteinase 7 and Gastric Cancer 
The matrix metalloproteinase (MMP) family is comprised of 25 proteins which use zinc 
ions to cleave their substrates. Collectively, MMPs modulate the activity of several 
microenvironment proteins including extracellular matrix (ECM) proteins, growth factors, 
cytokines, adhesion molecules and protease inhibitors
60-61,62
. The majority of MMPs have four 
domains: a signal domain for secretion, a pro-domain that keeps the protein in an inactive form, a 
zinc-binding domain for catalytic activity, and a hemopexin-like domain that confers substrate 
specificity
61
. MMPs are important for normal physiological processes, but also play an important 
role in many pathologic processes, including cancer
61,63
. In addition to having their expression 
upregulated relative to normal tissue in almost all cancers
62
, MMPs have been shown to 
participate in many of the hallmarks of cancer
64
, namely  cell growth, differentiation, apoptosis, 
migration, invasion, and angiogenesis
62
. One MMP that is important in gastric cancer 
specifically is matrix metalloproteinase 7 (MMP7). 
MMP7, also called Matrilysin and PUMP1, was first isolated from rat uterus
65
, and has 
since been identified in other tissues including skin, salivary glands, pancreas, liver, breast, 
intestine, urogenital tract, lungs and stomach
66
. While most MMPs are secreted from stromal or 
mesenchymal cells,  MMP7 is characteristically produced by epithelial cells
67
, though its 
expression has also been seen in macrophages and keratinocytes
66
. MMP7 has broad substrate 
specificity because it is a minimal-domain MMP
62
 and lacks the hemopexin domain which 
dictates substrate specificity
61
. MMP7 substrates include many ECM components including 
elastin, type IV collagen, fibronectin, vitronectin, aggrecan, and proteoglycans, and also non-
ECM components such as TNF-, FAS ligand, HB-EGF, E-cadherin, and B4-integrin
68–75
.  
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Increased expression of MMP7 has been observed in premalignant and malignant lesions 
in many organs including colon, pancreas and stomach
76,77–81
, and expression levels of MMP7 
are directly related to tumor staging
77,82–85
.  In a mouse model of breast cancer, over expression 
of MMP7 leads to hyperproliferation and increased cancer susceptibility
86
. Moreover, cell lines 
that overexpress MMP7 possess enhanced tumorigenic potential
87
. Finally, mice that are 
genetically predisposed to intestinal tumors have decreased intestinal tumorigenesis when bred 
onto a MMP7 null background
88
. Together, these observations suggest that MMP7 promotes 
carcinogenesis. 
 
MMP7 and H. pylori 
MMP7, like other MMPs, is generally expressed at low levels until it is induced by an 
extracellular signal. MMP7 expression is stimulated by a variety of signals, however bacterial 
contact is among the most potent inducers of MMP7 expression
89
. Given this observation, and 
that MMP7 has pro-tumorigenic activities, and that MMP7 is over expressed in pre-malignant 
lesions associated with H. pylori infection, studies were conducted to determine whether           
H. pylori induces MMP7 expression in gastric epithelial cells and whether MMP7 plays a role in 
H. pylori-induced gastric carcinogenesis
89
. Not only does H. pylori infection induce expression 
of MMP7 both in vitro and in vivo
67,89,90
, but induction in gastric epithelial cells seems to be       
H. pylori specific
89
. Induction of MMP7 is Cag-PAI and ERK1/2 dependent
67,89
, and two 
mechanisms of induction have been reported. It has been shown that MMP7 is induced by 
increased levels of gastrin
91
, and it has also been shown that H. pylori induces dephosphorylation 
and mislocalization of p120 from the cell membrane into the nucleus. There, p120 relieves 
KAISO-mediated repression of the MMP7 gene promoter
92
.  
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 H. pylori-induced expression of MMP7 may contribute to gastric carcinogenesis by 
augmenting cell proliferation as well as cell migration and invasion. MMP7 contributes to both 
epithelial and mesenchymal cell proliferation by increasing the bioavailability of IGF-II
93
, and 
MMP7 contributes to epithelial cell invasion and migration by cleaving proteins in the 
extracellular matrix
67
. MMP7 also contributes to cell invasion and migration by promoting 
epithelial to mesenchymal transition (EMT) by indirectly increasing levels of soluble HB-EGF
94
.  
 Given all of the previous data regarding MMP7 in gastric and other cancers, it was 
predicted that knocking out MMP7 would protect against injury in the context of H. pylori 
infection. Surprisingly, MMP7-/- mice infected with H. pylori actually exhibit higher 
inflammation and injury than infected wild-type mice
95
.  This suggests MMP7 may have an 
important role in modulating the inflammatory response to H. pylori infection. 
 
Summary and Objective 
In summary, the following findings have shaped the rational for this thesis.  (1) MMP7 is 
thought to play a role early in carcinogenesis
77–81
. (2) H. pylori-induced gastritis is an initiating 
event for gastric adenocarcinoma
5
. (3) MMP7-/- mice have increased inflammation following 
challenge with H. pylori
95
. (4) Macrophages are critical to inducing H. pylori-induced gastritis
58
. 
(5) Activated macrophage phenotypes are heavily dependent on the microenvironment
96
 and 
alterations in macrophage polarization can significantly contribute to diseases including 
cancers
96,97
. (6) MMP7 could alter the microenvironment as it is able to cleave components of 
the ECM as well as growth factors and cytokines
60–62
.  Taking these observations together, we 
sought to further elucidate whether MMP7 contributes to or protects the host from H. pylori-
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induced injury. Specifically this thesis strives to establish whether MMP7 alters macrophage 
polarization during H. pylori infection. 
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CHAPTER II 
 
MATERIALS AND METHODS 
 
H. pylori Strains 
H. pylori strains 60190, 7.13 and PMSS1 were grown on tryptic soy agar (TSA) plates 
supplemented with 5% sheep blood (BD BBL) in an atmosphere of 5% CO2 at 37° Celsius. 
Strains were passed every 24-48 hours for no more than 10 passages. To prepare strains for      
co-culture with mammalian cells, the strains were harvested from 24 hour old plates and grown 
in Brucella broth supplemented with 10% heat-inactivated neonatal calf serum (NCS) and 
20g/ml vancomycin and agitated in an atmosphere of 5% CO2 at 37° Celsius for 18 hours. The 
strains were then harvested by centrifugation at 4000 RPM for 5 minutes at room temperature, 
washed once in phosphate buffered saline (PBS), and resuspended in Royal Park Memorial 
Institute (RPMI) 1640 cell media (Mediatech, Inc). Bacterial strains were added to mammalian 
cells at a multiplicity of infection of 1:100.  
 
Cell Culture and Reagents 
 MKN28 human gastric epithelial cells were grown in RPMI 1640 supplemented with 
10% heat-inactivated fetal bovine serum (FBS), 2mM L-glutamine and HEPES in an atmosphere 
of 5% CO2 at 37° Celsius. Cells were grown for no more than 20 passages. 
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Bicinchoninic Acid (BCA) Protein Assay 
To determine the concentration of protein in cell lysates, Pierce BCA assays (Thermo 
Scientific 23225) were performed following manufacturer’s instructions. Briefly, protein 
samples were diluted 1:10 in water and incubated with 2 mL working reagent at 37° Celsius for 
30 minutes. Room temperature samples were read with a spectrophotometer at 562 nm. 
 
qRT-PCR 
RNA was isolated from MKN28 gastric epithelial cells or bone marrow derived 
macrophages (BMDM) using the Qiagen rnEASY kit (74104) according to manufacturer’s 
instructions. qRT-PCR was performed using Applied Biosystems High Capacity cDNA Reverse 
Transcription kit (4368814) followed by real-time PCR using Applied Biosystems Taqman gene 
expression assays using a 7300 real-time PCR system (Applied Biosystems). Mouse specific 
gene expression assays used include Nos2 (Mm00440502_m1), Arg1 (Mm00475988_m1), 
Tgfb1 (Mm01178820_m1), Il10 (Mm00439614_m1), Chi3I3 (Mm00657889_mH), Tnfsf14 
(Mm00444567_m1), Il1b (Mm00434228_m1), Il12a (Mm00434165_m1), and Retnla 
(Mm00445109_m1). Expression levels of target genes were normalized to expression levels of 
GAPDH (Mm99999915_g1).  
 
Mice and Experimental Infections 
All experiments were approved by the Vanderbilt Institutional Animal Care and Use 
Committee. INS-GAS MMP7-/- mice were obtained by breeding commercially available 
C57BL/6 MMP-/- and INS-GAS mice together (Jackson laboratories). INS-GAS MMP7-/- 
progeny were backcrossed with INS-GAS mice for 12 generations. Wild-type C57BL/6 mice 
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were commercially purchased through Jackson laboratories. All mice were specific pathogen 
free.  
6-8 week old wild-type and MMP7-/- C57BL/6 mice as well as wild-type and MMP7-/- 
INS-GAS mice were inoculated with 500l Brucella broth containing 5.0x109 colony forming 
units (CFU) H. pylori or Brucella broth alone via orogastric gavage. Inoculation occurred twice 
separated by 24 hours as described previously
35
. Mice were euthanized at 12 weeks post 
challenge. At necropsy, one half of the stomach was reserved for magnet assisted cell sorting, 
and the remaining half of the stomach was divided into three tissue strips. One strip was fixed in 
10% neutral buffered formalin and paraffin embedded by the Vanderbilt Human Tissue 
Acquisition and Pathology Shared Resource. One strip was homogenized, plated on TSA plates 
supplemented with 5% sheep blood and 2g/mL amphotericin, 30g/mLBacitracin, 10g/mL 
nalidixic acid and 20g/mL vancomycin, and incubated under microaerobic conditions at 37° 
Celsius. After 7 days CFU were counted and standardized to gram of tissue as described 
previously
35
. The remaining strip was frozen before its use in the Milliplex cytokine/chemokine 
magnetic bead panel (Millipore MCYTOMAG-70-PMX).  
 
Bone Marrow-Derived Macrophages 
Femurs were dissected from 8 week old wild-type and MMP7-/- C57BL/6 mice and 
flushed with PBS to harvest the bone marrow. The harvested marrow was homogenized using a 
21 gauge needle and strained through a 70M cell strainer. Red blood cells were lysed by 
resuspending the marrow in 900L of sterilized water for 20 seconds and immediately adding 
100l of 10X sterile PBS. To differentiate the cells into macrophages, remaining cells were 
plated at 1x10
6
 cells in 6 well tissue culture dishes in R20/30 Differentiation Media (RPMI 1640, 
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20% FBS, 30% L929 Cell Conditioned Media, 100U/mL penicillin, 100µg/mL Streptomycin, 
2mM L-glutamine). After 7 days, cells were washed, and the media was replaced with R10/5 
Differentiation Media (RPMI 1640, 10% FBS, 5% L929 Cell Conditioned Media, 2mM            
L-glutamine) for 24 hours prior to co-culture with H. pylori strain PMSS1 for 24 hours. 
 
Magnet Assisted Cell Sorting 
One half of the stomach tissue harvested as described above was brought back to the lab 
in 5mL ice cold RPMI 1640. The tissue was mechanically disrupted with sharp tip dissecting 
scissors and enzymatically digested with solution D (0.05% w/v collagenase, 2% w/v dispase in 
RPMI 1640) for 20 minutes with agitation at 37° Celsius. Following digestion, cells were filtered 
through a 70M nylon cell strainer, added to 5mL of fresh complete RPMI and centrifuged at 
2000 RPM for 10 minutes at 4° Celsius. The resulting pellet was resuspended in 100µL of   
biotin-conjugated F4/80 antibody (Caltag MF48015-3) diluted 1:250 in flow cytometry staining 
buffer solution (eBioscience 00-42222-26) and kept on ice for 20 minutes. Stained cells were 
washed once with in flow cytometry staining buffer solution and centrifuged as before. The 
resulting pellet was resuspended in 100L of streptavidin conjugated to micrometal beads 
(BDImag PUS557812) diluted 1:2 in flow cytometry staining buffer solution (eBioscience 00-
42222-26) and kept on ice for 20 minutes. The stained pellets were washed three times as 
follows. 1 mL of flow cytometry staining buffer solution was added to pellets, vortexed, and 
placed inside the magnetic apparatus (BD IMagnet 552311) for 5 minutes. Once the magnetic 
particles were visibly lined up against the magnet, the staining buffer was removed by pipette. 
Sorted cells were lysed with 200L of PerfectPure Lysis Solution (5PRIME 2302650). Cell 
lysates were frozen and later, RNA was isolated using the PerfectPure RNA 96 cell CS kit 
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(5prime 2302530) according to manufacturer’s instructions. Reverse transcriptase and real-time 
PCR was performed as above. 
 
Luminex-based Multiplex Assay 
Tissue from wild-type and MMP7-/- C57BL/6 mice stomachs was homogenized in 
200L of CelLytic MW Mammalian Tissue Lysis/Extraction Reagent (Sigma C3228-50ML) 
supplemented with protease inhibitor cocktails 2 and 3 (Sigma P0044-5ML and P5726-1ML) 
using a Qiagen TissueLyser (85300) set at 50 oscillations per second for 3 minutes. Protein 
extracts rested on ice for 10 minutes and were centrifuged for 10 minutes at 14,800 RPM at 4° 
Celsius. Cytokine and chemokine concentrations were determined using a Millipore Multiplex 
kit (MCYTOMAG-70K-PMX) according to manufacturer’s protocol. Briefly, 25µL of tissue 
sample, standard sample and quality controls were incubated with 25L of antibody coated 
beads overnight at 4
o
 Celsius with agitation. Plates were washed twice, and incubated with 25L 
of secondary antibody at room temperature for 1 hour at room temperature with agitation. 25L 
of streptavidin-RPE was added to each well and incubated at room temperature for 30 minutes 
with agitation. Plates were washed twice before adding 150L of sheath fluid. After 5 minutes of 
agitation the plates were read using Luminex xPONENT software and a FlexMap3D multiplex 
machine. Data were acquired according to manufacturer’s instructions using MILLIPLEX 
Analyst software, and analyzed with Microsoft Excel and graphed with Prism6 Graphpad 
software. 
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Tissue Staining 
To score inflammation in mouse gastric tissue, 5 M paraffin-embedded sections were 
stained with hemotoxylin and eosin by the Vanderbilt Human Tissue Acquisition and Pathology 
Shared Resource. A blinded pathologist scored acute and chronic inflammation, hyperplasia, and 
dysplasia in the antrum and corpus using an ordinal scale from 0-3. The scores from antrum and 
corpus were combined for a final score as described previously
95
.  
 
Statistical Analysis 
 Statistical significance was tested with student’s T test using GraphPad Prism 6 software. 
Significance was defined as P ≤ 0.05. 
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CHAPTER III 
 
RESULTS 
 
Loss of MMP7 Increases Inflammation In C57BL/6 and INS-GAS Mice 
Increased MMP7 expression has been observed in gastric carcinomas
76,77
 as well as 
premalignant lesions
77,78,81
, and levels of MMP7 are directly related to tumor staging
77,82–85
. 
Additionally, mice which are genetically predisposed to intestinal cancer experience decreased 
tumorigenesis when MMP7 is knocked out
88
. Together, these observations suggest that MMP7 
promotes gastric carcinogenesis. Therefore, it is surprising that in the context of H. pylori 
infection MMP7-/- mice have been shown to have more inflammation and injury than infected 
wild-type mice
95
 when inflammation is an initiating event for H. pylori-induced gastric 
carcinoma.  
Because it has been shown that the genetic background of mouse models can alter disease 
risk
98
, we sought to determine if the increased inflammation seen in H. pylori infected MMP7-/- 
mice is an artifact of the C57BL/6 background. To determine this, wild-type and MMP-/- 
C57BL/6 mice as well as wild-type and MMP-/- INS-GAS mice were challenged with H. pylori 
strain PMSS1 or Brucella broth control. Twelve weeks post challenge the mice were euthanized, 
and the stomachs were harvested for histological analysis (Figure 1). MMP7-/- mice had higher 
inflammation scores than wild-type mice for both the C57BL/6 (Figure 2 top panels) and       
INS-GAS backgrounds (Figure 2 bottom panels). Representative images are shown in Figure 3. 
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Figure 1 Experimental design 8 week old male mice were challenged with H. pylori strain PMSS1 
or Brucella broth control. 12 weeks after challenge stomach tissue was harvested from euthanized 
mice for analysis. One half of the stomach was divided into three strips. One strip was embedded in 
paraffin for histological analysis. One strip was homogenized and plated on TSA to confirm 
colonization of the animals. The final strip was homogenized and lysed for protein extract used in a 
multiplex cytokine analysis. RNA extracted from macrophages isolated from the remaining stomach 
tissue via magnet assisted cell sorting (MACS) was analyzed by qRT-PCR. 
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Figure 2 Increased inflammation in MMP7-/- mice Paraffin embedded sections of gastric tissue from 
H. pylori infected mice were stained with hemotoxylin and eosin. A blinded pathologist scored chronic 
and acute inflammation separately in the antrum and corpus using an ordinal scale (0-3) to represent no, 
mild, moderate and marked inflammation based on the presence of inflammatory infiltrate. The two 
scores from antrum and corpus were combined for a final inflammation score (0-6). Sections missing 
antrum (7 mice total) were excluded from this analysis. Red asterisk signifies statistical significance.  
* P ≤ 0.05 *** P ≤ 0.001 
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Figure 3 Representative images of increased inflammation in MMP7-/- mice Paraffin embedded 
sections of gastric tissue from H. pylori infected C57BL/6 (A) C57BL/6 MMP7-/- (B) INS-GAS (C) and 
INS-GAS MMP7-/- mice (D) were stained with hemotoxylin and eosin. Black boxes and arrows indicate 
areas with inflammatory infiltrate.  All panels are 10X magnification. 
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A B 
 19 
 
 
C57BL/6 mice rarely show any evidence of pre-malignant or malignant lesions prior to 
15 months of infection with H. pylori
99
, but INS-GAS mice can exhibit premalignant lesions as 
early as 6 weeks post challenge with H. pylori
100
. In this experiment, both the INS-GAS and 
MMP7-/- INS-GAS mice that were infected with H. pylori displayed pit abscesses and 
premalignant lesions. However,  the MMP7-/- INS-GAS mice had worse inflammation-induced 
injury than wild-type INS-GAS mice. Representative histological images of inflammation and 
injury are shown in Figure 5 respectively. MMP7-/- INS-GAS mice had increased hyperplasia 
evidenced by having a thicker mucosa than wild-type mice (Figure 5A and B). Wild-type     
INS-GAS mice exhibited indefinite dysplasia with some enlarged, darkened nuclei (Figure 5C 
box 1). Wild-type mice also had slightly irregularly shaped glands though the nuclei remained 
uncrowded (Figure 5C box 2). INS-GAS MMP7-/- mice displayed dysplasia with highly 
irregular, angular glands (Figure 5D box 1) and hyperchromatic nuclei in crowded cells 
demonstrating pseudo-stratification (Figure 5D box 2). Both wild-type and MMP7-/- INS-GAS 
mice displayed abscesses. However, lesions in MMP7-/- mice were larger and more numerous 
(Figure 5E and F).  
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Figure 4 Increased premalignant lesions in MMP7-/- mice Paraffin embedded sections of gastric 
tissue from H. pylori infected mice were stained with hemotoxylin and eosin. A blinded pathologist 
scored hyperplasia and dysplasia separately in the antrum and corpus using an ordinal scale (0-3) to 
represent no, mild, moderate and marked characteristics. Hyperplasia was scored on the thickness of 
the mucosa. Dysplasia was scored on physical appearance of cells and the architecture of the glands. 
The two scores from antrum and corpus were combined for final scores (0-6). Sections missing 
antrum (1 mouse) were excluded from this analysis. 
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Figure 5 Representative images of increased injury in MMP7-/- mice Paraffin embedded sections of gastric tissue from H. pylori infected INS-GAS 
(top panels) and INS-GAS MMP7-/- mice (bottom panels) were stained with hemotoxylin and eosin. Black boxes indicate areas of dysplasia. Black arrows 
indicate abscesses.  Panels A-D are 10X magnification. Panels E-F are 20X magnification. 
 22 
 
 
Similar Colonization Is Seen In Wild-type and MMP7-/- Mice  
It is possible that the MMP7-/- mice had more inflammation because they were colonized 
with more bacteria. Therefore, we sought to determine the colonization of each infected mouse. 
One strip of stomach tissue from each mouse was homogenized, and the homogenate was plated 
on TSA plates for 7 days (Figure 1). Colonization data for wild-type and MMP7-/- mice are 
graphed in Figure 6.  There is no statistically significant difference in colonization between 
wild-type and MMP7-/- mice for either the C57BL/6 or INS-GAS backgrounds. 
 
 
 
 
 
 
 
 
 
Figure 6 Similar colonization in wild-type and MMP-/- mice To assess colonization, gastric tissue 
from H. pylori infected mice was homogenized and plated on TSA agar for 7 days. Colony forming 
units (CFU) were standardized to grams of homogenized tissue. 
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Loss of MMP7 Increases Production of Inflammatory Cytokines 
We sought to determine if MMP7-/- mice have a different cytokine profile from wild-
type mice. To examine this, protein lysates of homogenized stomach tissue from H. pylori 
infected mice was were analyzed by multiplex assay (Figure 1).  Of the twenty-five factors 
analyzed, one factor (IFN-) was induced in wild-type mice but not MMP7-/- mice (Figure 7A). 
Five factors (IL-1, IL-1, IL-7, MIP-1, and TNF-) were induced in MMP7-/- mice but not 
wild-type mice (Figure 7B-7F).  Three factors (IL-17, IP-10 and RANTES) were induced in 
both wild-type and MMP7-/- mice, but had higher induction in the MMP7-/- mice compared to 
wild-type mice (Figure 7G-7I). 
 
Loss of MMP7-/- Increases Expression of M1 Macrophage Markers 
Macrophages are critical for establishing H. pylori induced gastritis
58
. Activated 
macrophage phenotypes are transient, and the process by which they acquire a phenotype is 
known as macrophage polarization
57–65
.  The type of macrophages that exist in a tissue is heavily 
dependent on the type, concentration and half-life of the factors present in the 
microenvironment
96
. MMP7 is a promiscuous protease that cleaves many different factors. Here, 
we have shown that loss of MMP7 alters the cytokine/chemokine profile of H. pylori-infected 
mice. Given that MMP7 has been shown to control distinct transcriptional responses in airway 
epithelial cells infected with Pseudomonas aeruginosa
108
, and that  mice genetically engineered 
to lack another MMP, MMP10, have been shown to lack M2 macrophages in a chemically-
induced colitis model
109
,  we hypothesized that MMP7 could induce transcriptional programs 
that alter macrophage polarization in response to H. pylori. To test this in vitro, we challenged 
bone-marrow derived macrophages from wild-type and MMP7-/- C57BL/6 mice
 24 
 
 
Figure 7 Cytokines induced by H. pylori 8 week old male wild-type and MMP7-/- C57BL6 mice were 
challenged with H. pylori strain PMSS1 or Brucella broth alone. 12 weeks after challenge with H. pylori 
mice were euthanized and stomach tissue was harvested for multiplex analysis. Samples were excluded 
from the analysis if the cytokine concentration fell outside of the standard curve. Red asterisk signifies 
statistical significance. *P ≤ 0.05 ** P ≤ 0.005  
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with H. pylori and analyzed expression of various M1, M2 and Mreg macrophage markers by 
qRT-PCR. Of the 9 markers analyzed two, IFN-γ and IL-1β, had statistically significant higher 
expression in MMP7-/- mice compared to wild-type mice (Figure 8).  
To extend these findings in vivo we isolated macrophages from the stomachs of wild-type 
and MMP7-/- C57BL/6 mice infected with H. pylori and examined the expression of M1 
markers by qRT-PCR (Figure 1). The results were similar to those from the bone marrow-
derived macrophages with iNOS and IL-1 having higher expression in macrophages isolated 
from MMP7-/- mice compared to macrophages isolated from wild-type mice (Figure 9). 
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Figure 8 Increased expression of M1 markers in MMP7-/- bone marrow derived macrophages 
Bone marrow was harvested from the femurs of 8 week old male wild-type and MMP7-/- C57BL/6 
mice. Red blood cells were lysed and the remaining harvested cells were differentiated to 
macrophages in vitro. Following 24 hour co-culture with H. pylori strain PMSS1 RNA was isolated 
and qRT-PCR was performed to analyze expression of markers of M1 (A-C) M2 (D-F) and Mreg (G-
I) macrophages. Red asterisk signifies statistical significance. * P ≤ 0.05 
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Figure 9 Increased expression of M1 markers in MMP7-/- macrophages isolated by MACS 8 week old male wild-type and MMP7-/- C57BL6 mice were 
challenged with H. pylori strain PMSS1 or Brucella broth control. 12 weeks after challenge the mice were euthanized and stomach tissue was harvested and 
digested. Macrophages were then isolated by magnet assisted cell sorting with an F4/80 antibody. RNA was isolated from the sorted cells and qRT-PCR was 
performed to analyze expression of M1 macrophage markers. Red asterisk signifies statistical significance. ** P ≤ 0.01 
iN O S
iN
O
S
 m
R
N
A
 f
o
ld
 o
v
e
r
u
n
in
f
e
c
t
e
d
 w
il
d
-
t
y
p
e
 c
o
n
t
r
o
l
C
5
7
B
L
/6
 
C
5
7
B
L
/6
 -
/-
0
1
2
3
4
P = .0 8
I L -1 2
I
L
-
1
2

 m
R
N
A
 f
o
ld
 o
v
e
r
u
n
in
f
e
c
t
e
d
 w
il
d
-
t
y
p
e
 c
o
n
t
r
o
l
C
5
7
B
L
/6
 
C
5
7
B
L
/6
 -
/-
0
2
4
6
8
1 0
IL -1
I
L
-
1

 m
R
N
A
 f
o
ld
 o
v
e
r
u
n
in
f
e
c
t
e
d
 w
il
d
-
t
y
p
e
 c
o
n
t
r
o
l
C
5
7
B
L
/6
 
C
5
7
B
L
/6
 -
/-
0
1
2
3
4
* *
A B C
 28 
 
 
CHAPTER IV 
 
DISCUSSION 
 
Collectively, several observations suggest that MMP7 promotes carcinogenesis. For 
example, increased expression of MMP7 has been observed in premalignant and malignant 
lesions in many organs including colon, pancreas and stomach
76,77–81
, and expression levels of 
MMP7 are directly related to tumor staging
77,82–85
. Moreover, MMP7 contributes to the 
proliferation, tumorigenic potential, migration and invasion of cells
67,86,87
, and mice that are 
genetically predisposed to intestinal tumors have decreased intestinal tumorigenesis when bred 
onto a MMP7-/- background
88
. Because MMP7 expression is induced by the carcinogenic 
bacteria H. pylori it was predicted that loss of MMP7 would be beneficial to a host infected with 
H. pylori. Thus, it was surprising that MMP7-/- mice experience increased inflammation in 
response to H. pylori infection
95
, when gastritis is believed to be the initiating event for gastric 
cancers
5
. The objective of this thesis was to elucidate an explanation for the surprising increase 
in inflammation seen in H. pylori-infected MMP7-/- mice.  
 
Increased Inflammation in MMP7-/- Mice Is Not an Artifact of the C57BL/6 Background 
Because it has been shown that the genetic background of mouse models can alter disease 
risk
98
 one possible explanation for the increased inflammation seen in MMP7-/- mice is that it is 
an artifact of the C57BL/6 background. An alternative explanation is that the previous results 
were an unfortunate type II statistical error. To address these two possibilities we repeated the 
initial experiment. We infected wild-type and MMP7-/- C57BL/6 mice with H. pylori strain 
 29 
 
 
PMSS1 and examined inflammation 12 weeks post challenge. Additionally, wild-type and 
MMP7-/- INS-GAS mice (of the FVB genetic background) were included in the analysis  
(Figure 1). Again, there was increased inflammation seen in the MMP7-/- mice on both the 
C57BL6 and INS-GAS backgrounds (Figure 2 and 3).  INS-GAS mice are more susceptible to 
malignant transformation in response to H. pylori infection than C57BL/6 mice
95
. Importantly, in 
our experiment, MMP7-/- INS-GAS mice had increased severity of pre-malignant lesions and 
tissue injury compared to wild-type INS-GAS mice (Figure 3 and 4). 
 To determine if the increased inflammation could have been a result of increased 
colonization, we determined the colonization of each infected mouse by counting CFU from 
stomach tissue homogenate plated on TSA plates (Figure 1). There was no statistically 
significant difference in colonization between wild-type and MMP7-/- mice for either the 
C57BL/6 or INS-GAS backgrounds (Figure 5). Collectively, these results suggest that the 
increase in inflammation seen in MMP7-/- mice is neither an artifact of the C57BL/6 background 
nor a type II statistical error. Therefore, we sought to elucidate a mechanism by which loss of 
MMP7 results in increased inflammation. 
 
MMP7 suppresses M1 macrophage polarization during H. pylori infection 
Gastritis is thought to be an initiating event for the majority of gastric carcinomas
5
, and 
macrophages have been shown to be critical for initiating gastritis in response to H. pylori
58
. 
Because MMP7 is thought to play a role early in carcinogenesis
77–81
, and we have shown that it 
plays a role in shaping the cytokine profile in response to H. pylori, we considered the possibility 
that MMP7 could play a role in the macrophage polarization during H. pylori infection. 
 30 
 
 
For several decades, activated macrophages were thought to only play a role in clearing 
pathogens from the body
101
. However, recent research has demonstrated that there are different 
activated macrophage phenotypes which serve important roles in both normal and pathological 
processes
57–65
. M1 macrophages (also known as classically activated macrophages) are important 
for clearing pathogens from the body, and do so by intracellular microbiacidal activity
96
 and by 
secreting inflammatory mediators. M1 macrophages promote a Th1 adaptive immune response 
while simultaneously dampening the Th2 type response
105,110
. M2 macrophages are important for 
wound healing and tissue remodeling
96
. In addition to secreting components of the extracellular 
matrix
96
, M2 macrophages also secrete factors to promote a Th2 adaptive immune response 
while simultaneously dampening a Th1 response
105,110
. Regulatory macrophages (Mregs) like 
M2 macrophages are anti-inflammatory but unlike M2 macrophages do not deposit extracellular 
matrix
96
.    
Macrophage polarization is heavily influenced by the microenvironment as evidenced by 
the fact that macrophages that are identical other than their microenvironments will respond 
differently to identical stimuli
96
. Macrophage polarization is reversible, and is not only 
dependent on the type of stimulating factor, but also the concentration and half-life of the 
stimulating factors present in the microenvironment
96
. Proinflammatory, pathogen clearing M1 
macrophages polarize in response to IFN- and TNF- Anti-inflammatory/wound-healing M2 
macrophages polarize in response to IL-4 and IL-13. Anti-inflammatory regulatory Mregs 
polarize in response to IL-10.  Given the wide variety of MMP7 substrates, and given that 
MMP7 has been shown to induce distinct transcriptional responses in epithelial cells
108
 in 
addition to the belief that aberrations in macrophage polarization can contribute to cancer
96,97
, we 
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hypothesized that loss of MMP7 could alter the cytokine profile of the microenvironment and 
thus alter macrophage polarization in response to H. pylori.  
To test this hypothesis, we examined the cytokine profiles of stomach tissue from wild-
type and MMP7-/- mice infected with H. pylori. Multiplex analysis revealed eight inflammatory 
cytokines that were expressed more highly in MMP7-/- mice compared to wild-type mice 
(Figure 7). Two of these factors include IL-1β, a cytokine effector secreted by M1 
macrophages
102
, and TNF-α, a potent inducer of M1 macrophage polarization101. We also 
examined expression of macrophage markers both from bone-marrow derived macrophages from 
wild-type and MMP7-/- mice challenged with H. pylori in vitro and from macrophages isolated 
from the stomachs of wild-type and MMP7-/- mice infected with H. pylori in vivo. Both analyses 
revealed an increase in expression of the M1 macrophage markers iNOS and IL-1β. Together, 
these observations suggest that loss of MMP7 results in increased M1 macrophage polarization. 
Therefore, in a MMP7+/+ host, MMP7 may suppress M1 macrophage polarization. Given that 
M1 macrophages can contribute to cancer development by releasing toxic oxygen and nitrogen 
intermediates that induce DNA damage and mutations
111
, this would suggest that MMP7 
normally plays an important role in protecting the host from H. pylori-induced gastric 
carcinogenesis.  
 
Future Directions  
Although H. pylori colonizes 50% of the world’s population, and is the highest risk factor 
for developing gastric cancer, only 1% of infected individuals develop gastric cancer
5
.  It is 
widely believed that a patient’s disease outcome is ultimately the result of interplay between 
environmental factors, bacterial virulence factors, and host factors. Results from this study 
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suggest that MMP7 could be a host factor that determines gastric cancer risk. It is possible that 
differences in MMP7 polymorphisms could explain why some patients infected with H. pylori 
develop gastric cancer and others do not. For example, patients with a polymorphism that 
decreases MMP7 activity could be susceptible to increased M1 polarization in response to        
H. pylori infection, thus putting them at higher risk for developing gastric cancer. Therefore, an 
important follow up study is to analyze publicly available sequence data from human gastric 
biopsies from healthy patients and patients with gastric cancer to see if any differences in MMP7 
gene sequence correlate with patient outcome.  
One reason gastric cancer is so deadly is that often it is not diagnosed until it has already 
reached end stage disease. Having a genetic marker such as MMP7 could help identify patients 
infected with H. pylori that are at higher risk for cancer. Identified patients could be observed 
more closely for signs of malignant transformation, and earlier detection would save the lives of 
many gastric cancer patients. One argument against this approach is that this may not be 
currently practical given that the majority of gastric cancer patients live in developing countries. 
However, the cost of gene sequencing is decreasing significantly over time as technology 
improves, and therefore could be more achievable in the future.  
 
 
 
 
 
 
 
 33 
 
 
REFERENCES 
 
 
1. World Health Organization. (2012).at 
<http://www.who.int/mediacentre/factsheets/fs297/en/> 
2. Crew, K. D. & Neugut, A. I. Epidemiology of gastric cancer. World journal of 
gastroenterology : WJG 12, 354–62 (2006). 
3. Yamamoto, S. Multipoint Oncology Teleconference , Japan. VII, 471–475 (2001). 
4. Kelley, J. R. & Duggan, J. M. Gastric cancer epidemiology and risk factors. Journal of 
Clinical Epidemiology 56, 1–9 (2003). 
5. Peek, R. M. & Blaser, M. J. Helicobacter pylori and gastrointestinal tract 
adenocarcinomas. Nature reviews. Cancer 2, 28–37 (2002). 
6. Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 
759–767 (1990). 
7. Wroblewski, L. E., Peek, R. M. & Wilson, K. T. Helicobacter pylori and gastric cancer: 
factors that modulate disease risk. Clinical microbiology reviews 23, 713–39 (2010). 
8. Marshall, B. & Warren, J. R. UNIDENTIFIED CURVED BACILLI IN THE STOMACH 
OF PATIENTS WITH GASTRITIS AND PEPTIC ULCERATION. The Lancet 323, 
1311–1315 (1984). 
9. Fox, J. G. et al. Concurrent enteric helminth infection modulates inflammation and gastric 
immune responses and reduces helicobacter-induced gastric atrophy. Nature medicine 6, 
536–42 (2000). 
10. Whary, M. T. et al. Intestinal helminthiasis in Colombian children promotes a Th2 
response to Helicobacter pylori: possible implications for gastric carcinogenesis. Cancer 
epidemiology, biomarkers & prevention : a publication of the American Association for 
Cancer Research, cosponsored by the American Society of Preventive Oncology 14, 
1464–9 (2005). 
11. Saxena, A. et al. Association of Helicobacter pylori and Epstein-Barr virus with gastric 
cancer and peptic ulcer disease. Scandinavian journal of gastroenterology 43, 669–74 
(2008). 
12. Hino, R. et al. Activation of DNA methyltransferase 1 by EBV latent membrane protein 
2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Cancer 
research 69, 2766–74 (2009). 
 34 
 
 
13. Tabassam, F. H., Graham, D. Y. & Yamaoka, Y. Helicobacter pylori activate epidermal 
growth factor receptor- and phosphatidylinositol 3-OH kinase-dependent Akt and 
glycogen synthase kinase 3beta phosphorylation. Cellular microbiology 11, 70–82 (2009). 
14. Lee, S.A., D. Kang, K. N. Shim, J. W. Choe, W. S. Hong, and H. C. Effect of diet and 
Helicobacter pylori infection to the risk of early gastric cancer. J. Epidemiology 13, 162–
168 (2003). 
15. Shikata, K. et al. A prospective study of dietary salt intake and gastric cancer incidence in 
a defined Japanese population: the Hisayama study. International journal of cancer. 
Journal international du cancer 119, 196–201 (2006). 
16. Tsugane, S. Salt, salted food intake, and risk of gastric cancer: epidemiologic evidence. 
Cancer science 96, 1–6 (2005). 
17. Gamboa-Dominguez, A. et al. Salt and stress synergize H. pylori-induced gastric lesions, 
cell proliferation, and p21 expression in Mongolian gerbils. Digestive diseases and 
sciences 52, 1517–26 (2007). 
18. Kato, S. et al. High salt diets dose-dependently promote gastric chemical carcinogenesis 
in Helicobacter pylori-infected Mongolian gerbils associated with a shift in mucin 
production from glandular to surface mucous cells. International journal of cancer. 
Journal international du cancer 119, 1558–66 (2006). 
19. Zhang, S. et al. Hyperosmotic stress enhances interleukin-1beta expression in 
Helicobacter pylori-infected murine gastric epithelial cells in vitro. Journal of 
gastroenterology and hepatology 21, 759–66 (2006). 
20. Nozaki, K. et al. Synergistic Promoting Effects of Helicobacter pylori Infection and High-
salt Diet on Gastric Carcinogenesis in Mongolian Gerbils. Cancer Science 93, 1083–1089 
(2002). 
21. Fox, J. G. et al. High-Salt Diet Induces Gastric Epithelial Hyperplasia and Parietal Cell 
Loss, and Enhances Helicobacter pylori Colonization in C57BL/6 Mice. Cancer Res. 59, 
4823–4828 (1999). 
22. Gancz, H., Jones, K. R. & Merrell, D. S. Sodium chloride affects Helicobacter pylori 
growth and gene expression. Journal of bacteriology 190, 4100–5 (2008). 
23. Loh, J. T., Torres, V. J. & Cover, T. L. Regulation of Helicobacter pylori cagA expression 
in response to salt. Cancer research 67, 4709–15 (2007). 
24. Peek, R. M. et al. Detection of Helicobacter pylori gene expression in human gastric 
mucosa. Journal of clinical microbiology 33, 28–32 (1995). 
 35 
 
 
25. Peek RM Jr, Miller GG, Tham KT, Perez-Perez GI, Zhao X, Atherton JC, B. M. 
Heightened inflammatory response and cytokine expression in vivo to CagA+ 
Helicobactor pylori strains. Laboratory investigation 73, 760–770 (1995). 
26. Cover, T. L., Dooley, C. P. & Blaser, M. J. Characterization of and human serologic 
response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing 
cytotoxin activity. Infect. Immun. 58, 603–610 (1990). 
27. CRABTREE, J. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic 
ulceration, and gastric pathology. The Lancet 338, 332–335 (1991). 
28. Kuipers, E. J., Perez-Perez, G. I., Meuwissen, S. G. M. & Blaser, M. J. Helicobacter pylori 
and Atrophic Gastritis: Importance of the cagA Status. JNCI Journal of the National 
Cancer Institute 87, 1777–1780 (1995). 
29. Crabtree, J. E. et al. Systemic and mucosal humoral responses to Helicobacter pylori in 
gastric cancer. Gut 34, 1339–1343 (1993). 
30. Blaser, M. J. et al. Infection with Helicobacter pylori Strains Possessing cagA Is 
Associated with an Increased Risk of Developing Adenocarcinoma of the Stomach. 
Cancer Res. 55, 2111–2115 (1995). 
31. Parsonnet, J., Friedman, G. D., Orentreich, N. & Vogelman, H. Risk for gastric cancer in 
people with CagA positive or CagA negative Helicobacter pylori infection. Gut 40, 297–
301 (1997). 
32. Yang, J. J. et al. Oncogenic CagA promotes gastric cancer risk via activating ERK 
signaling pathways: a nested case-control study. PloS one 6, e21155 (2011). 
33. Tsutsumi, R., Takahashi, A., Azuma, T., Higashi, H. & Hatakeyama, M. Focal adhesion 
kinase is a substrate and downstream effector of SHP-2 complexed with Helicobacter 
pylori CagA. Molecular and cellular biology 26, 261–76 (2006). 
34. Tsutsumi, R., Higashi, H., Higuchi, M., Okada, M. & Hatakeyama, M. Attenuation of 
Helicobacter pylori CagA x SHP-2 signaling by interaction between CagA and C-terminal 
Src kinase. The Journal of biological chemistry 278, 3664–70 (2003). 
35. Franco, A. T. et al. Activation of beta-catenin by carcinogenic Helicobacter pylori. 
Proceedings of the National Academy of Sciences of the United States of America 102, 
10646–51 (2005). 
36. Suzuki, M. et al. Interaction of CagA with Crk plays an important role in Helicobacter 
pylori-induced loss of gastric epithelial cell adhesion. The Journal of experimental 
medicine 202, 1235–47 (2005). 
 36 
 
 
37. Saadat, I. et al. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial 
cell polarity. Nature 447, 330–3 (2007). 
38. Murata-Kamiya, N. et al. Helicobacter pylori CagA interacts with E-cadherin and 
deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric 
epithelial cells. Oncogene 26, 4617–26 (2007). 
39. Amieva, M. R. et al. Disruption of the epithelial apical-junctional complex by 
Helicobacter pylori CagA. Science (New York, N.Y.) 300, 1430–4 (2003). 
40. Leunk, R. D., Johnson, P. T., David, B. C., Kraft, W. G. & Morgan, D. R. Cytotoxic 
activity in broth-culture filtrates of Campylobacter pylori. Journal of Medical 
Microbiology 26, 93–99 (1988). 
41. Papini, E. Cellular Vacuoles Induced by Helicobacter pylori Originate from Late 
Endosomal Compartments. Proceedings of the National Academy of Sciences 91, 9720–
9724 (1994). 
42. Cover, T. L., Krishna, U. S., Israel, D. A. & Peek, R. M. Induction of gastric epithelial cell 
apoptosis by Helicobacter pylori vacuolating cytotoxin. Cancer research 63, 951–7 
(2003). 
43. Galmiche, A. et al. The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating 
cytotoxin targets mitochondria and induces cytochrome c release. The EMBO journal 19, 
6361–70 (2000). 
44. Manente, L. et al. The Helicobacter pylori’s protein VacA has direct effects on the 
regulation of cell cycle and apoptosis in gastric epithelial cells. Journal of cellular 
physiology 214, 582–7 (2008). 
45. Peek, R. M. et al. Helicobacter pylori Strain-specific Genotypes and Modulation of the 
Gastric Epithelial Cell Cycle. Cancer Res. 59, 6124–6131 (1999). 
46. Willhite, D. C., Cover, T. L. & Blanke, S. R. Cellular vacuolation and mitochondrial 
cytochrome c release are independent outcomes of Helicobacter pylori vacuolating 
cytotoxin activity that are each dependent on membrane channel formation. The Journal 
of biological chemistry 278, 48204–9 (2003). 
47. Rhead, J. L. et al. A new Helicobacter pylori vacuolating cytotoxin determinant, the 
intermediate region, is associated with gastric cancer. Gastroenterology 133, 926–36 
(2007). 
48. Ogiwara, H. et al. Role of deletion located between the intermediate and middle regions of 
the Helicobacter pylori vacA gene in cases of gastroduodenal diseases. Journal of clinical 
microbiology 47, 3493–500 (2009). 
 37 
 
 
49. Atherton, J., Cao, P., Peek, RM Jr., Tummurur, M., Blaser, MJ., and Cover, T. Mosaicism 
in Vacuolating Cytotoxin Alleles of Helicobacter pylori. Journal of Biological Chemistry 
270, 17771–17777 (1995). 
50. Atherton, J., Peek, R., Tham, K., Cover, T. & Blaser, M. Clinical and pathological 
importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter 
pylori. Gastroenterology 112, 92–99 (1997). 
51. Miehlke, S. et al. The Helicobacter pylori vacA s1, m1 genotype and cagA is associated 
with gastric carcinoma in Germany. International journal of cancer. Journal international 
du cancer 87, 322–7 (2000). 
52. Basso, D. et al. Clinical relevance of Helicobacter pylori cagA and vacA gene 
polymorphisms. Gastroenterology 135, 91–9 (2008). 
53. Douraghi, M. et al. Multiple gene status in Helicobacter pylori strains and risk of gastric 
cancer development. Digestion 80, 200–7 (2009). 
54. Hussein, N. R. et al. Differences in virulence markers between Helicobacter pylori strains 
from Iraq and those from Iran: potential importance of regional differences in H. pylori-
associated disease. Journal of clinical microbiology 46, 1774–9 (2008). 
55. Wilson, K. T. & Crabtree, J. E. Immunology of Helicobacter pylori: insights into the 
failure of the immune response and perspectives on vaccine studies. Gastroenterology 
133, 288–308 (2007). 
56. Algood, H. M. S., Gallo-Romero, J., Wilson, K. T., Peek, R. M. & Cover, T. L. Host 
response to Helicobacter pylori infection before initiation of the adaptive immune 
response. FEMS immunology and medical microbiology 51, 577–86 (2007). 
57. Asim, M. et al. Helicobacter pylori induces ERK-dependent formation of a phospho-c-Fos 
c-Jun activator protein-1 complex that causes apoptosis in macrophages. The Journal of 
biological chemistry 285, 20343–57 (2010). 
58. Schumacher, M. a et al. Gastric Sonic Hedgehog acts as a macrophage chemoattractant 
during the immune response to Helicobacter pylori. Gastroenterology 142, 1150–1159.e6 
(2012). 
59. Wilson, K. T. & Crabtree, J. E. Immunology of Helicobacter pylori: insights into the 
failure of the immune response and perspectives on vaccine studies. Gastroenterology 
133, 288–308 (2007). 
60. Nagase, H. Matrix Metalloproteinases. Journal of Biological Chemistry 274, 21491–
21494 (1999). 
 38 
 
 
61. Wilson, C. L. & Matrisian, L. M. Matrilysin: An epithelial matrix metalloproteinase with 
potentially novel functions. The International Journal of Biochemistry & Cell Biology 28, 
123–136 (1996). 
62. Egeblad, M. & Werb, Z. New functions for the matrix metalloproteinases in cancer 
progression. Nature reviews. Cancer 2, 161–74 (2002). 
63. Coussens, L. M., Fingleton, B. & Matrisian, L. M. Matrix metalloproteinase inhibitors and 
cancer: trials and tribulations. Science (New York, N.Y.) 295, 2387–92 (2002). 
64. Hanahan, D. & Weinberg, R. A. The Hallmarks of Cancer. Cell 100, 57–70 (2000). 
65. Woessner, J. F. & Taplin, C. J. Purification and properties of a small latent matrix 
metalloproteinase of the rat uterus. The Journal of biological chemistry 263, 16918–25 
(1988). 
66. Burke, B. The role of matrix metalloproteinase 7 in innate immunity. Immunobiology 209, 
51–56 (2004). 
67. Wroblewski, L. E. et al. Stimulation of MMP-7 (matrilysin) by Helicobacter pylori in 
human gastric epithelial cells: role in epithelial cell migration. Journal of cell science 116, 
3017–26 (2003). 
68. Gearing, A. J. et al. Processing of tumour necrosis factor-alpha precursor by 
metalloproteinases. Nature 370, 555–557 (1994). 
69. Mohan, M. J. et al. The Τumor Necrosis Factor-α Converting Enzyme (TACE):  A Unique 
Metalloproteinase with Highly Defined Substrate Selectivity †. Biochemistry 41, 9462–
9469 (2002). 
70. Powell, W. C., Fingleton, B., Wilson, C. L., Boothby, M. & Matrisian, L. M. The 
metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and 
potentiates epithelial cell apoptosis. Current Biology 9, 1441–1447 (1999). 
71. Vargo-Gogola, T., Crawford, H. C., Fingleton, B. & Matrisian, L. M. Identification of 
novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas 
ligand. Archives of Biochemistry and Biophysics 408, 155–161 (2002). 
72. Cheng, K., Xie, G. & Raufman, J.-P. Matrix metalloproteinase-7-catalyzed release of HB-
EGF mediates deoxycholyltaurine-induced proliferation of a human colon cancer cell line. 
Biochemical pharmacology 73, 1001–12 (2007). 
73. Yu, W.-H., Woessner, J. F., McNeish, J. D. & Stamenkovic, I. CD44 anchors the 
assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor 
and ErbB4 and regulates female reproductive organ remodeling. Genes & development 16, 
307–23 (2002). 
 39 
 
 
74. Noe, V. et al. Release of an invasion promoter E-cadherin fragment by matrilysin and 
stromelysin-1. J. Cell Sci. 114, 111–118 (2001). 
75. von Bredow, D.C., R. B. Nagle, G.T. Bowden, and A. . C. Cleavage of beta 4 integrin by 
matrilysin. Exp Cell Res 236, 341–345 (1997). 
76. Crawford, H. C. et al. The metalloproteinase matrilysin is a target of beta-catenin 
transactivation in intestinal tumors. Oncogene 18, 2883–91 (1999). 
77. McDonnell, S., Navre, M., Coffey, R. J. & Matrisian, L. M. Expression and localization of 
the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas. 
Molecular Carcinogenesis 4, 527–533 (1991). 
78. Saarialho-Kere, U. K. et al. Enhanced expression of matrilysin, collagenase, and 
stromelysin-1 in gastrointestinal ulcers. The American journal of pathology 148, 519–26 
(1996). 
79. Takeuchi, N. et al. Matrilysin gene expression in sporadic and familial colorectal 
adenomas. Molecular carcinogenesis 19, 225–9 (1997). 
80. Crawford, H. C., Scoggins, C. R., Washington, M. K., Matrisian, L. M. & Leach, S. D. 
Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates 
acinar-to-ductal metaplasia in exocrine pancreas. 109, 1403–1404 (2002). 
81. Chung, W. C. et al. The detection of Helicobacter pylori cag pathogenicity islands (PAIs) 
and expression of matrix metalloproteinase-7 (MMP-7) in gastric epithelial dysplasia and 
intramucosal cancer. Gastric cancer : official journal of the International Gastric Cancer 
Association and the Japanese Gastric Cancer Association 13, 162–9 (2010). 
82. Honda, M., Mori, M., Ueo, H., Sugimachi, K. & Akiyoshi, T. Matrix metalloproteinase-7 
expression in gastric carcinoma. Gut 39, 444–448 (1996). 
83. Yamashita, K., Azumano, I., Mai, M. & Okada, Y. Expression and tissue localization of 
matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implications for 
vessel invasion and metastasis. International journal of cancer. Journal international du 
cancer 79, 187–94 (1998). 
84. Senota, a et al. Relation of matrilysin messenger RNA expression with invasive activity in 
human gastric cancer. Clinical & experimental metastasis 16, 313–21 (1998). 
85. Hippo, Y. et al. Global Gene Expression Analysis of Gastric Cancer by Oligonucleotide 
Microarrays. Cancer Res. 62, 233–240 (2002). 
86. Rudolph-Owen, L. A., Chan, R., Muller, W. J. & Matrisian, L. M. The Matrix 
Metalloproteinase Matrilysin Influences Early-Stage Mammary Tumorigenesis. Cancer 
Res. 58, 5500–5506 (1998). 
 40 
 
 
87. Witty, J. P. et al. Modulation of Matrilysin Levels in Colon Carcinoma Cell Lines Affects 
Tumorigenicity in Vivo. Cancer Res. 54, 4805–4812 (1994). 
88. Wilson, C. L., Heppner, K. J., Labosky, P. A., Hogan, B. L. M. & Matrisian, L. M. 
Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. 
Proceedings of the National Academy of Sciences 94, 1402–1407 (1997). 
89. Crawford, H. C. et al. Helicobacter pylori. 5085, 1125–1136 (2003). 
90. Bebb, J. R. Helicobacter pylori upregulates matrilysin (MMP-7) in epithelial cells in vivo 
and in vitro in a Cag dependent manner. Gut 52, 1408–1413 (2003). 
91. Varro, A. et al. Increased gastric expression of MMP-7 in hypergastrinemia and 
significance for epithelial-mesenchymal signaling. American journal of physiology. 
Gastrointestinal and liver physiology 292, G1133–40 (2007). 
92. Ogden, S. R. et al. p120 and Kaiso Regulate Helicobacter pylori-induced Expression of 
Matrix Metalloproteinase-7. 19, 4110–4121 (2008). 
93. McCaig, C. et al. The role of matrix metalloproteinase-7 in redefining the gastric 
microenvironment in response to Helicobacter pylori. Gastroenterology 130, 1754–63 
(2006). 
94. Yin, Y. et al. Helicobacter pylori potentiates epithelial:mesenchymal transition in gastric 
cancer: links to soluble HB-EGF, gastrin and matrix metalloproteinase-7. Gut 59, 1037–45 
(2010). 
95. Ogden, S. R. et al. Matrix metalloproteinase-7 and premalignant host responses in 
Helicobacter pylori-infected mice. Cancer research 70, 30–5 (2010). 
96. Cassetta, L., Cassol, E. & Poli, G. Macrophage polarization in health and disease. 
TheScientificWorldJournal 11, 2391–402 (2011). 
97. Biswas, S. K. & Mantovani, A. Macrophage plasticity and interaction with lymphocyte 
subsets: cancer as a paradigm. Nature immunology 11, 889–96 (2010). 
98. Lifsted, T. et al. Identification of inbred mouse strains harboring genetic modifiers of 
mammary tumor age of onset and metastatic progression. International journal of cancer. 
Journal international du cancer 77, 640–4 (1998). 
99. Rogers, A. B. et al. Helicobacter pylori but not high salt induces gastric intraepithelial 
neoplasia in B6129 mice. Cancer research 65, 10709–15 (2005). 
100. Fox, J. G. et al. Host and microbial constituents influence helicobacter pylori-induced 
cancer in a murine model of hypergastrinemia. Gastroenterology 124, 1879–1890 (2003). 
 41 
 
 
101. Mosser, D. M. The many faces of macrophage activation. Journal of Leukocyte Biology 
73, 209–212 (2003). 
102. Mantovani, A. et al. The chemokine system in diverse forms of macrophage activation 
and polarization. Trends in immunology 25, 677–86 (2004). 
103. Mantovani, A., Sica, A. & Locati, M. Macrophage polarization comes of age. Immunity 
23, 344–6 (2005). 
104. Martinez, F. O., Gordon, S., Locati, M. & Mantovani, A. Transcriptional Profiling of the 
Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and 
Patterns of Gene Expression. J. Immunol. 177, 7303–7311 (2006). 
105. Mosser, D. M. & Edwards, J. P. Exploring the full spectrum of macrophage activation. 
Nature reviews. Immunology 8, 958–69 (2008). 
106. Murray, P. J. & Wynn, T. a Obstacles and opportunities for understanding macrophage 
polarization. Journal of leukocyte biology 89, 557–63 (2011). 
107. Sica, A. & Mantovani, A. Science in medicine Macrophage plasticity and polarization : in 
vivo veritas. 122, 787–795 (2012). 
108. Kassim, S. Y. et al. Individual matrix metalloproteinases control distinct transcriptional 
responses in airway epithelial cells infected with Pseudomonas aeruginosa. Infection and 
immunity 75, 5640–50 (2007). 
109. Fingleton, B. MMP10: Friend or Foe? (2011). 
110. Mantovani, A., Sozzani, S., Locati, M., Allavena, P. & Sica, A. Macrophage polarization: 
tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. 
Trends in immunology 23, 549–55 (2002). 
111. Mantovani, A., Allavena, P., Sica, A. & Balkwill, F. Cancer-related inflammation. Nature 
454, 436–44 (2008).  
 
